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Natural antibodies (NAbs) are pre-existing antibodies with germline origin that arise in the
absence of previous exposure to foreign antigens. NAbs are produced by B-1 lymphocytes
and are primarily of the IgM isotype. There is accumulating evidence that – in addition to
their role in antimicrobial host defense – NAbs exhibit important housekeeping functions
by facilitating the non-immunogenic clearance of apoptotic cells as well as the removal of
(neo-)self antigens. These properties are largely mediated by the ability of NAbs to rec-
ognize highly conserved and endogenously generated structures, which are exemplified
by so-called oxidation-specific epitopes (OSEs) that are products of lipid peroxidation. The
generation of OSEs as well as their interaction with the immune system have been studied
extensively in the context of atherosclerosis, a chronic inflammatory disease of the vascu-
lar wall that is characterized by the accumulation of cellular debris and oxidized low-density
lipoproteins (OxLDL). Both apoptotic cells as well as OxLDL carry OSEs that are targeted by
NAbs. Therefore, OSEs represent stress-induced neo self-structures that mediate recog-
nition of metabolic waste (e.g., cellular debris) by NAbs, allowing its safe disposal, which
has fundamental implications in health and disease.
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B-1 CELLS ARE THE PRODUCERS OF NATURAL IGM
ANTIBODIES
In contrast to conventional B-2 cells, B-1 cells have a self-
replenishing capacity, are localized to the pleural and peritoneal
cavities, and exhibit different activation requirements (Martin and
Kearney, 2001; Montecino-Rodriguez and Dorshkind, 2006). A
major function of B-1 cells is their capacity to secrete natural
antibodies (NAbs), which are produced very early in life. NAbs
are pre-existing antibodies, whose variable regions are encoded
by germline (or near germline) encoded variable genes. They are
termed “natural” due to the fact that their development does not
depend on foreign antigen exposure, and therefore a normal NAb
repertoire is found at equivalent titers in the blood of mice housed
in completely “germ”-free conditions (Avrameas, 1991; Notkins,
2004). NAbs are primarily of the IgM isotype and bind both self
and foreign antigens by recognizing highly conserved structures of
nucleic acids, (glyco)proteins, and (phospho)lipids that are present
on the surface of microbes such as bacteria, viruses, and fungi
(Briles et al., 1982; Choi and Baumgarth, 2008; Rapaka et al., 2010),
and endogenous (neo-)self antigens, respectively. Through this,
NAbs are critically involved in the first line defense against micro-
bial pathogens and exhibit“housekeeping” functions by regulating
tissue homeostasis (Avrameas, 1991; Notkins, 2004).
For example, mice deficient in secreted IgM (sIgM-/-) show
increased susceptibility to acute peritonitis in a cecal ligation punc-
ture model (Jenck et al., 1998), but also a stronger tendency of
developing an auto-immune phenotype upon LPS injection or
when crossed onto the lupus prone lpr background (Boes et al.,
2000). Moreover, sIgM-/- mice display impaired T-cell responses
when immunized with suboptimal dosages of antigen and an
abnormal B cell development with increased B-1 and marginal
zone B cell numbers. These data also point to an important role
in immune regulation. Due to their specificity for altered self-
structures, NAbs have also been suggested to play a role in tumor
immunosurveillance (Vollmers and Brandlein, 2007; Schwartz-
Albiez et al., 2008) as well as in neurodegenerative disorders such
as Alzheimer’s disease (Szabo et al., 2008), which are conditions
that are characterized by the alteration of self-structures.
OXIDATION-SPECIFIC EPITOPES
In the last years it has become increasingly apparent that lipid per-
oxidation results in the generation of specific structures that are
recognized by pattern recognition receptors (PRR) of the innate
immune system (Chou et al., 2008; Weismann and Binder, 2012).
These include humoral responses, such as NAbs, complement
factor H, C reactive protein, as well as cellular receptors, such
as scavenger receptor CD36 and TLR-4. Thus, oxidation-specific
epitopes (OSEs) constitute a novel class of damage-associated mol-
ecular patterns (DAMPs) targeted by both PRRs as well as soluble
pattern recognition proteins (Miller et al., 2011). The peroxidation
of phospholipids occurs ubiquitously as a physiological process,
but is strongly enhanced during pathological situations. Thus,
oxidation products are generated and accumulate in essentially
all inflammatory settings, including atherosclerosis, pulmonary,
renal, and liver diseases, and diseases affecting the central nervous
system, such as multiple sclerosis and Alzheimer’s disease (Neale
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et al., 1994; Palinski et al., 1996; Dei et al., 2002; Casado et al.,
2006; Sanchez et al., 2006; Imai et al., 2008; Haider et al., 2011). As
a consequence of the inflammatory response, highly reactive lipid
peroxidation products are generated, which in turn are capable of
modifying autologous proteins and lipids leading to the generation
of altered self-structures. These processes were initially studied
and characterized in oxidized low-density lipoproteins (OxLDL),
which is a prominent component of atherosclerotic lesions. Dur-
ing atherogenesis, LDL accumulates in the vascular wall, where it
is subjected to oxidative modifications leading to the generation
of OxLDL. The oxidation of LDL has been shown to result in
the formation of numerous lipid peroxidation-derived structures
(OSEs) that are capable of triggering robust immune responses
(Chou et al., 2009). For example, when the oxidation-prone sn-
2 polyunsaturated fatty acid of phosphatidylcholine (the main
phospholipid of LDL) undergoes oxidation, breakdown products,
such as malondialdehyde (MDA) with its many advanced con-
densation products, 4-hydroxynonenal (4-HNE), and the remain-
ing “core aldehyde” 1-palmitoyl-2-(5-oxovaleroyl)-sn-glycero-3-
phosphocholine (POVPC) are formed (Horkko et al., 2000). These
then modify autologous molecules and generate (often repeti-
tive) adducts that are recognized by various immune receptors
in a hapten-specific manner. In order to study the antigenicity of
OxLDL, a variety of model antigens have been established, includ-
ing the frequently used CuSO4-oxidized LDL (CuOx-LDL) and
malondialdehyde-modified LDL (MDA-LDL). Other model anti-
gens include bovine serum albumin modified with either MDA,
4-HNE, or POVPC.
Importantly, cells undergoing apoptotic cell death are exposed
to enhanced oxidative stress as well, which also leads to the gen-
eration of oxidized lipids, such as cardiolipin, phosphatidylserine,
and phosphatidylcholine (Chang et al., 2004; Kagan et al., 2004).
Indeed, all of the OSEs described above have also been found on
the membranes of apoptotic cells and cellular debris, where they
represent tags by which components of innate immunity can dis-
tinguish dying cells from viable cells – a property that is critically
important for immune homeostasis.
NAbs AND OSEs
The first identification of NAbs with specificity for OSEs came
from the seminal observation that atherosclerotic Apolipoprotein
E deficient mice (Apoe-/-) were found to have very high titers of
autoantibodies to epitopes of OxLDL (Palinski et al., 1996). This
enabled Dr. Witztum’s laboratory to clone a large set of hybridomas
producing IgM antibodies with specificity for OxLDL model anti-
gens from the spleens of non-immunized atherosclerotic Apoe-/-
mice. Of these hybridomas, a CuOx-LDL-specific clone, termed
E06, was found to specifically bind the phosphocholine (PC) head-
group of oxidized but not native unoxidized phosphatidylcholine,
indicating that E06 binds to OxLDL via oxidized phospholipids
(Friedman et al., 2002). A detailed sequence analysis of the CDR3
region of E06 revealed it to be of 100% germline origin and iden-
tical to a prototypic NAb called T15 (Shaw et al., 2000). T15 (an
IgA) is a well known PC-specific NAb that is exclusively derived
from B-1 cells (Masmoudi et al., 1990). It has been shown to bind
S. pneumoniae, which contain PC as prominent constituent of the
(lipo)teichoic acid components of the cell wall polysaccharide,
thereby protecting mice from pneumococcal infections (Briles
et al., 1982). Moreover, immunization of cholesterol-fed ather-
osclerosis prone LDL receptor deficient (Ldlr-/-) mice with heat-
killed extracts of R36a S. pneumoniae containing PC resulted in
high anti-OxLDL IgM titers, which were found to be nearly all of
the T15/E06 clonotype, and significantly reduced atherosclerotic
plaque development (Binder et al., 2003). This atheroprotective
effect of T15/E06 Abs was further confirmed by a study in which
passive infusion of a monoclonal T15/E06id+ IgM preparation
reduced vein graft atherosclerosis in Apoe-/- mice (Faria-Neto
et al., 2006). Several mechanisms have been proposed by which
T15/E06 mediates this protection from atherosclerosis. Because
PC is also found on apoptotic cell membranes, T15/E06 IgM may
inhibit atherogenesis by facilitating a proper clearance of apop-
totic cells (Shaw et al., 2000; Ogden et al., 2005; Chen et al.,
2009b). Indeed, impaired clearance of apoptotic cells has been
found to promote atherosclerotic lesion formation (Ait-Oufella
et al., 2007; Thorp et al., 2008). In line with this, it has been shown
that T15/E06 IgM Abs enhance the clearance of apoptotic cells by
a mechanism that is dependent on the co-recruitment of C1q and
mannose-binding lectin (Chen et al., 2009b). Moreover, it has been
shown that T15/E06 is able to restore the complement dependent
clearance of apoptotic cells in B cell-deficient and sIgM-/- mice,
respectively (Ogden et al., 2005; Chen et al., 2009a). Mice defi-
cient in sIgM when crossed onto the Ldlr-/- background develop
accelerated atherosclerosis, further supporting the protective role
of NAbs in hypercholesterolemia-induced oxidative stress (Lewis
et al., 2009). In addition, splenectomized Ldlr-/- mice, which have
strongly reduced peritoneal B-1a cell numbers and consequently
reduced serum IgM levels, develop accelerated atherosclerosis that
could be rescued by adoptive transfer of B-1a cells isolated from
naïve donors but not from sIgM-/- mice. It has been proposed that
a more efficient clearance of cellular debris in mice reconstituted
with wild type B-1a cells (which include OSE-specific B-1 cells) is
responsible for the protective effect (Kyaw et al., 2011).
Apart from these clearance properties, T15/E06 has also been
demonstrated to exhibit protective functions by neutralizing the
pro-inflammatory effects of oxidized phospholipids. For example,
macrophages respond to oxidized 1-palmitoyl-2-arachidonoyl-sn-
glycero-3-phosphorylcholine (OxPAPC) stimulation by secreting
IL-6, and this pro-inflammatory effect of OxPAPC was inhibited
upon co-treatment with T15/E06 Abs (Imai et al., 2008). These
protective properties of T15/E06 involve its ability to block the
recognition of OxPAPC by the macrophage scavenger receptor
CD36 (Horkko et al., 1999; Binder et al., 2003; Stewart et al., 2010).
Moreover, apoptotic cells or blebs (also called microvesicles) that
carry OSEs were shown to activate endothelial cells resulting in
increased monocyte adhesion (Huber et al., 2002; Chang et al.,
2004; Liu et al., 2012), and T15/E06 has been shown to inhibit this
effect (Huber et al., 2002; Chang et al., 2004).
Additional NAbs with specificity for other OSEs have also been
identified. A monoclonal IgM NAb named E014 cloned from the
spleens of atherosclerotic Apoe-/- mice has been shown to bind
MDA-LDL as well as apoptotic cells (Palinski et al., 1996; Chang
et al., 1999). Moreover, E014 can bind to apoptotic blebs and – as
recently demonstrated – to cholesterol induced microvesicles that
carry MDA-epitopes on their surface (Huber et al., 2002; Liu et al.,
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Table 1 | Natural IgM antibodies recognize oxidation-specific epitopes present on apoptotic cells and OxLDL and modulate their inflammatory
properties.
NAbs OSEs Properties/Functions
T15/E06 PC head-group of oxidized
phosphatidylcholine
Blockage of OxLDL uptake by macrophages (Horkko et al., 1999; Binder et al., 2003)
Binding to OxLDL and apoptotic cells and atherosclerotic lesions (Palinski et al., 1996; Chang et al., 1999, 2004)
Inhibition of apoptotic cell/blebs mediated endothelial cell activation resulting in decreased monocyte adhesion
(Huber et al., 2002; Chang et al., 2004)
Inhibition OxPAPC-induced IL-6 secretion by lung tissue macrophage (Imai et al., 2008)
Enhancement of in vivo apoptotic cell clearance in B cell-deficient (µMT) and sIgM-/- mice (Ogden et al., 2005;
Chen et al., 2009a)
Protection from atherosclerosis (Binder et al., 2003; Faria-Neto et al., 2006)
Clinical score reduction in collagen induced arthritis (Chen et al., 2009a)
E014 Malondialdehyde
Binding to OxLDL, apoptotic cells, and atherosclerotic lesions (Palinski et al., 1996)
Binding to apoptotic and cholesterol induced microvesicles (Huber et al., 2002; Liu et al., 2012)
NA-17 Malondialdehyde
Binding to OxLDL and apoptotic cells (Chou et al., 2009)
Enhancement of clearance of apoptotic cells by macrophages in Rag1-/- mice in vivo (Chou et al., 2009)
LR01 Oxidized cardiolipin Binding to OxLDL, apoptotic cells, and atherosclerotic lesions (Tuominen et al., 2006)
2012). Both may represent important pro-inflammatory targets of
NAbs in atherosclerotic lesions. Finally, another germline-encoded
NAb with specificity for OxLDL has been isolated from the spleens
of atherosclerotic Ldlr-/- mice. This clone, named LR01, was found
to be directed against oxidized but not native cardiolipin, and was
also shown to bind apoptotic but not viable cells (Tuominen et al.,
2006).
All these NAbs have remarkable specificity for their cognate
antigens, as they do not exhibit cross-reactivity. For example,
E06 binds PC-adducts but not MDA-adducts, while E014 binds
MDA-adducts but not PC-adducts. Although these OSEs are
often present on the surface of the same antigens (e.g., apop-
totic cells, OxLDL), the selectivity for different but ubiquitous
oxidation-specific structures underscores the critical need of NAbs
recognizing OSEs (Binder, 2010; see Table 1).
To directly address the relative contribution of OSE-specific
NAbs to the entire pool of B-1 cell derived NAbs, we selectively
reconstituted Rag1-/- mice with B-1 cells from naïve donor mice.
Detailed analysis of the serum of reconstituted mice solely express-
ing B-1 cell derived Ig, revealed that ∼30% of all IgM Abs had
specificity for different OSEs, including MDA, 4-HNE, and PC.
Notably, MDA-type adducts were found to be the most promi-
nently bound epitopes among the tested antigens. These results
were also supported by the finding that nearly 12% of all IgM
secreting cells in the spleens of reconstituted mice had speci-
ficity for MDA-epitopes, and similar results were also observed
with splenocytes of naïve unchallenged mice. Furthermore, an
MDA-specific NAb, termed NA-17, was cloned from the spleens of
B-1 cell reconstituted mice, and CDR3 sequence characterization
revealed complete germline origin of the V-D-J rearrangement of
the heavy chain and only one nucleotide insertion (C) at the splice
site of the VL and JL germline gene segments of the light chain.
This NAb was also shown to bind apoptotic cells and to promote
their clearance by peritoneal macrophages in Rag1-/- mice in vivo
(Chou et al., 2009).
In summary, a large part of NAbs has been shown to recognize
different OSEs that are present on OxLDL, apoptotic cells, and
cellular debris. Similar to PC epitopes on S. pneumoniae, equiva-
lent structures for other OSEs such as MDA have been suggested
to be present on the surface of P. gingivalis (Turunen et al., 2012).
Therefore, through the recognition of the same epitopes, NAbs
have the capacity to protect from the pathological accumula-
tion of self antigens and defend against microbial infections (see
Figure 1). An impaired function of NAbs may therefore result in
chronic inflammation as well as increased susceptibility to certain
infections.
B-1 CELLS AND OSE-SPECIFIC NABs IN HUMAN HEALTH
AND DISEASE
Circulating antibodies with specificity for OSEs, such as PC and
MDA have been shown to be also present in healthy subjects. We
have previously shown that a major proportion (∼50%) of IgM in
human umbilical cord blood, which serves as a good surrogate for
NAbs in humans, binds to apoptotic cells by their ability to recog-
nize MDA-adducts that are present on their surface. Interestingly,
we also found that compared to adult blood NAbs in umbilical cord
blood are particularly enriched for specificities to CuOx-LDL and
MDA-LDL, which are prototypic B-1 cell antigens in mice (Chou
et al., 2009). Recently, the human B-1 cell equivalent has been iden-
tified. Griffin et al. analyzed purified human B cell populations for
B-1 cell characteristics that have been described in mice, including
spontaneous IgM secretion, efficient T-cell stimulation, and tonic
intracellular signaling. Based on these they determined a small
population of B cells, present in umbilical cord and adult periph-
eral blood, and identified them as CD20+CD27+CD43+CD70−
(Griffin et al., 2011). Of note, these cells display B cell receptors
(BCRs) with binding specificities for a dsDNA-mimotope and for
the classic B-1 cell antigen PC, which is the cognate antigen of the
murine T15/E06 NAb. These data suggest that OSE-specific IgM
are also secreted by B-1 cells in humans.
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FIGURE 1 | Overview of protective properties of NAbs specific to OSEs. NAbs exhibit housekeeping and host defense functions by targeting OSEs on the
surface of apoptotic cells, self antigens, and microbial agents. Insufficient NAbs titers may lead to impaired clearance of cellular debris and reduced protective
capacity from invading pathogens. Accumulation of apoptotic material can trigger auto-immune responses and promote chronic inflammatory diseases.
Accumulating evidence points to a protective role for OSE-
specific IgM antibodies in cardiovascular disease. CuOx-LDL-
and MDA-LDL-specific IgM, but not IgG, titers in the serum
of patients were shown to be inversely correlated with carotid
intima-media thickness and the risk of developing a >50%
diameter stenosis in the coronary arteries, respectively (Karvo-
nen et al., 2003; Tsimikas et al., 2007). Moreover, anti-PC IgM
antibody titers have been shown to be inversely correlated with
cardiovascular disease risk in lupus patients (Anania et al., 2010;
Gronwall et al., 2012) as well as with an increased incidence
of strokes (Fiskesund et al., 2010) and heart attacks (Gron-
lund et al., 2009). These epidemiological findings are particularly
interesting, as human B-1 cells that produce NAbs have been
found to decline with age (Griffin et al., 2011). Thus, it can
be speculated that in older individuals the capacity to produce
protective NAbs is reduced, which could further enhance the
cardiovascular risk.
CONCLUSION
B-1 cell derived NAbs exhibit crucial housekeeping functions by
recognizing OSEs that are present on apoptotic cells and OxLDL.
As a result of this binding capacity, NAbs facilitate the non-
inflammatory clearance of apoptotic material preventing the accu-
mulation of debris that may lead to auto-immune/inflammatory
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responses. The clearance properties of NAbs are particularly
important in the context of chronic inflammation, which is
characterized by increased oxidative stress. In such conditions the
increased generation of neo-self antigens as well as the accumu-
lation of debris following tissue damage are the main sources of
inflammation. Moreover, the clearance capacity of NAbs may not
be sufficient in advanced chronic inflammatory conditions. There-
fore the identification of mechanisms and methods that enhance
NAb production may provide a novel approach for the treatment
of such pathological conditions.
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